Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: CHECK OUT THE 400,000 STOCK OPTION BY BIBEAU
1. 200,000 of the stock options shall vest on September 17, 2008. The remaining 200,000 stock options shall vest upon the successful completion of certain merger and acquisition related criteria.
Share
New Message
Please login to post a reply